[1]
|
杨芳. 舒芬太尼诱发呛咳反应的研究进展[J]. 中国城乡企业卫生, 2023, 38(1): 42-44.
|
[2]
|
付红玲, 马玲娥, 罗宗荣, 等. 右美托咪定预防高原地区老年患者全麻诱导期舒芬太尼诱发呛咳的效果观察[J]. 基层医学论坛, 2023, 27(13): 142-144.
|
[3]
|
刘惠子, 马鑫, 罗艳. 右美托咪定在功能神经外科的围手术期应用进展[J]. 国际麻醉学与复苏杂志, 2021, 42(3): 283-287.
|
[4]
|
Kaye, A.D., Chernobylsky, D.J., Thakur, P., et al. (2020) Dexmedetomidine in Enhanced Recovery after Surgery (ERAS) Protocols for Postoperative Pain. Current Pain and Headache Reports, 24, 21. https://doi.org/10.1007/s11916-020-00853-z
|
[5]
|
徐巧芳, 卞清明, 刘辉. 右美托咪定减轻全麻诱导期芬太尼诱发呛咳反应的临床效果[J]. 江苏医药, 2019, 45(11): 1156-1158.
|
[6]
|
孙继雄, 刘圣, 陆慧红, 等. 不同剂量地佐辛预防舒芬太尼诱发呛咳反应的临床观察[J]. 国际麻醉学与复苏杂志, 2015(7): 602-604.
|
[7]
|
Ambesh, S.P., Singh, N., Gupta, D., et al. (2010) A Huffing Manoeuvre, Immediately before Induction of Anaesthesia, Prevents Fentanyl-Induced Coughing: A Prospective, Randomized, and Controlled Study. British Journal of Anaesthesia, 104, 40-43. https://doi.org/10.1093/bja/aep333
|
[8]
|
王玥, 刁玉刚, 李林. 瑞马唑仑对颅内血管瘤患者舒芬太尼麻醉诱导所致呛咳反应的影响[J]. 实用药物与临床, 2023, 26(12): 1070-1073.
|
[9]
|
朱伟超. 右美托咪定与地塞米松对全麻诱导时舒芬太尼诱发呛咳的疗效对比[D]: [硕士学位论文]. 太原: 山西医科大学, 2022.
|
[10]
|
Agarwal, A., Gautam, S., Nath, S.S., et al. (2007) Comparison of the Incidence and Severity of Cough Induced by Sufentanil and Fentanyl: A Prospective, Randomised, Double-Blind Study. Anaesthesia, 62, 1230-1232. https://doi.org/10.1111/j.1365-2044.2007.05249.x
|
[11]
|
Tanaka, M. and Maruyama, K. (2003) Cough Reflex Induced by Microinjection of Citric Acid into the Larynx of Guinea Pigs: New Coughing Model. Journal of Pharmacological Sciences, 93, 465-470. https://doi.org/10.1254/jphs.93.465
|
[12]
|
El, B.M., Taha, S.K. and Siddik-Sayyid, S.M. (2014) Fentanyl-Induced Cough—Pathophysiology and Prevention. Middle East Journal of Anesthesiology, 22, 449-456.
|
[13]
|
成健, 杨洋, 杨改生. 不同给药速度和方法对舒芬太尼诱发的不良反应的影响[J]. 中国医刊, 2016, 51(6): 107-110.
|
[14]
|
许智鸿, 潘艳, 廖庆武. 舒芬太尼诱发呛咳反应机制及预防用药的研究进展[J]. 中国临床医学, 2019, 26(6): 951-954.
|
[15]
|
He, J., Zhu, L., Zhu, H., et al. (2018) Dose Selection of Central or Peripheral Administration of Sufentanil Affect Opioid Induced Cough? A Prospective, Randomized, Controlled Trial. BMC Anesthesiology, 18, Article No. 38. https://doi.org/10.1186/s12871-018-0502-z
|
[16]
|
可丽楠. 右美托咪定的临床麻醉应用进展[J]. 中国城乡企业卫生, 2023, 38(11): 30-32.
|
[17]
|
Bosch, O.G., Dornbierer, D.A., Bavato, F., et al. (2023) Dexmedetomidine in Psychiatry: Repurposing of Its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties. Pharmacopsychiatry, 56, 44-50.
|
[18]
|
方韬, 方莲, 林丽. 右美托咪定的临床应用和潜在风险[J]. 浙江临床医学, 2022, 24(11): 1581-1584.
|
[19]
|
曹婷, 霍建臻, 王文文. 不同剂量右美托咪定对全麻高血压手术患者的镇痛效果及安全性[J]. 临床医学研究与实践, 2022, 7(7): 108-111.
|
[20]
|
赵世军, 李银宏, 刘磊, 等. 右美托咪定对脑出血患者神经细胞保护及氧化应激反应的影响[J]. 中国老年学杂志, 2023, 43(4): 829-832.
|
[21]
|
张伟, 张加强, 孟凡民. 右美托咪定对单肺通气过程中炎性反应及氧化应激反应的影响[J]. 临床麻醉学杂志, 2013, 29(3): 229-231.
|
[22]
|
郭琼梅, 周长浩, 张建波, 等. 右美托咪定对单肺通气患者肺组织NF-κB表达及血浆TNF-α和ICAM-1水平的影响[J]. 河北医科大学学报, 2016, 37(3): 301-305.
|
[23]
|
谢辉兰, 顾连兵, 卞清明, 等. 右美托咪定联合利多卡因抑制芬太尼全麻诱导期的呛咳反应[J]. 江苏大学学报(医学版), 2015, 25(4): 366-368.
|
[24]
|
Weinger, M.B., Chen, D.Y., Lin, T., et al. (1995) A Role for CNS Alpha-2 Adrenergic Receptors in Opiate-Induced Muscle Rigidity in the Rat. Brain Research, 669, 10-18. https://doi.org/10.1016/0006-8993(94)01216-5
|
[25]
|
Groeben, H., Mitzner, W. and Brown, R.H. (2004) Effects of the alpha2-Adrenoceptor Agonist Dexmedetomidine on Bronchoconstriction in Dogs. Anesthesiology, 100, 359-363. https://doi.org/10.1097/00000542-200402000-00026
|
[26]
|
王茂华, 张静, 赵梦雅, 等. 不同浓度芬太尼对诱发呛咳时间与发生率的影响[J]. 中国医药导报, 2018, 15(13): 85-88.
|
[27]
|
周惟. 全麻下静注利多卡因与右美托咪定应用效果的对比分析[D]: [硕士学位论文]. 沈阳: 沈阳医学院, 2023.
|
[28]
|
赵琛, 尚会杰. 右美托咪定与利多卡因抑制芬太尼诱发全麻诱导期患者呛咳反应效果的比较[J]. 中国实用医刊, 2014(20): 87-89.
|
[29]
|
Bhalotra, A.R., Arya, M., Singh, R., et al. (2024) Comparative Evaluation of Nebulized versus Intravenous Dexmedetomidine on Intubating Conditions during Awake Fiberoptic Nasotracheal Intubation. Journal of Clinical Anesthesia, 95, Article ID: 111461. https://doi.org/10.1016/j.jclinane.2024.111461
|